After a year of regulatory warnings and safety debates over "Low T" drugs, it's no surprise that drugmakers like Eli Lilly ($LLY) and AbbVie ($ABBV) expect their testosterone sales to suffer in 2015. But as the mainstream medical community apparently moves away from testosterone replacement meds, specialized clinics are taking up the charge. All over the U.S., clinics that distribute the meds are popping up--across the South in particular. The FDA and EMA may discourage use of the drugs for "lifestyle purposes," but these centers encourage men to do just that. More